Please provide your email address to receive an email when new articles are posted on . Electrographic flow-guided ablation was associated with improvement in freedom from atrial fibrillation at 1 ...
MENLO PARK, Calif., Feb. 3, 2023 /PRNewswire/ -- Ablacon, Inc., an Ajax Health and Zeus Health-backed developer of an innovative mapping system to guide the treatment of atrial fibrillation (AF), ...
MENLO PARK, Calif., Feb. 1, 2024 /PRNewswire/ -- Cortex announced today the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in late October 2023. The international, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results